OTCMKTS:GNGBY GETINGE AB/ADR Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GETINGE AB/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $21.11 -0.04 (-0.19 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$21.11Now: $21.11▼$21.1150-Day Range$20.25MA: $21.90▼$23.4652-Week Range$13.20Now: $21.11▼$24.64Volume3,250 shsAverage Volume6,652 shsMarket Capitalization$5.37 billionP/E Ratio37.04Dividend Yield0.52%Beta0.77 ProfileAnalyst RatingsChartCompetitorsDividendEarningsHeadlinesShort InterestSocial Media Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for GETINGE AB/ADR. Previous Next 2.3 Community Rank Outperform VotesGETINGE AB/ADR has received 114 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGETINGE AB/ADR has received 136 “underperform” votes. (Add your “underperform” vote.)Community SentimentGETINGE AB/ADR has received 54.40% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about GETINGE AB/ADR and other stocks. Vote “Outperform” if you believe GNGBY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GNGBY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGETINGE AB/ADR has a dividend yield of 0.52%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthGETINGE AB/ADR does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, GETINGE AB/ADR insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.02% of the stock of GETINGE AB/ADR is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of GETINGE AB/ADR is 37.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.60.Price to Earnings Ratio vs. SectorThe P/E ratio of GETINGE AB/ADR is 37.04, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.12.Price to Book Value per Share RatioGETINGE AB/ADR has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNGBY Previous Symbol CUSIPN/A CIKN/A Webwww.getinge.com Phone46-1-033-500-00Debt Debt-to-Equity Ratio0.49 Current Ratio2.20 Quick Ratio1.42Price-To-Earnings Trailing P/E Ratio37.04 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.81 billion Price / Sales1.91 Cash Flow$1.62 per share Price / Cash Flow13.00 Book Value$8.15 per share Price / Book2.59Profitability EPS (Most Recent Fiscal Year)N/A Net Income$129.29 million Net Margins5.48% Return on Equity9.97% Return on Assets4.57%Miscellaneous Employees10,420 Outstanding Shares254,152,000Market Cap$5.37 billion Next Earnings Date9/30/2020 (Estimated) OptionableNot Optionable $21.11 -0.04 (-0.19 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive GNGBY News and Ratings via Email Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions How has GETINGE AB/ADR's stock been impacted by COVID-19 (Coronavirus)? GETINGE AB/ADR's stock was trading at $16.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GNGBY stock has increased by 29.6% and is now trading at $21.11. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of GETINGE AB/ADR? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GETINGE AB/ADR in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for GETINGE AB/ADR. When is GETINGE AB/ADR's next earnings date? GETINGE AB/ADR is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020. View our earnings forecast for GETINGE AB/ADR. How often does GETINGE AB/ADR pay dividends? What is the dividend yield for GETINGE AB/ADR? GETINGE AB/ADR declared an annual dividend on Thursday, June 18th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.114 per share on Monday, July 20th. This represents a dividend yield of 0.61%. The ex-dividend date is Monday, June 29th. This is a boost from GETINGE AB/ADR's previous annual dividend of $0.07. View GETINGE AB/ADR's dividend history. Are investors shorting GETINGE AB/ADR? GETINGE AB/ADR saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,400 shares, an increase of 600.0% from the August 31st total of 200 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is presently 0.4 days. View GETINGE AB/ADR's Short Interest. Who are some of GETINGE AB/ADR's key competitors? Some companies that are related to GETINGE AB/ADR include SONOVA HLDG AG/ADR (SONVY), Varian Medical Systems (VAR), Masimo (MASI), CONMED (CNMD), CONMED (CNMD), LivaNova (LIVN), InMode (INMD), BioLife Solutions (BLFS), Zynex (ZYXI), Natus Medical (NTUS), Viewray (VRAY), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR) and Cutera (CUTR). View all competitors. Who are GETINGE AB/ADR's key executives? GETINGE AB/ADR's management team includes the following people: Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 47)Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 47)Lars Mattson, Head of Investor RelationsMs. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 54)Mr. Abraham Ronai, Gen. Counsel What is GETINGE AB/ADR's stock symbol? GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY." How do I buy shares of GETINGE AB/ADR? Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is GETINGE AB/ADR's stock price today? One share of GNGBY stock can currently be purchased for approximately $21.11. How big of a company is GETINGE AB/ADR? GETINGE AB/ADR has a market capitalization of $5.37 billion and generates $2.81 billion in revenue each year. GETINGE AB/ADR employs 10,420 workers across the globe. What is GETINGE AB/ADR's official website? The official website for GETINGE AB/ADR is www.getinge.com. How can I contact GETINGE AB/ADR? GETINGE AB/ADR's mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected] This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
